alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc

Term ID

CHEBI:59296

Synonyms

6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranose
alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GlcNAc
alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranose
beta-D-glucopyranose, O-6-deoxy-alpha-L-galactopyranosyl-(1->2)-O-beta-D-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-
Fuca1-2Galb1-3GlcNAcb
Fucalpha1-2Galbeta1-3GlcNAcbeta
globo-H
H type I
H type I epitope
human blood group H type 1 trisaccharide
O-6-deoxy-alpha-L-galactopyranosyl-(1->2)-O-beta-D-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose

Definition

An amino trisaccharide consisting of α-L-fucose, β-D-galactose and N-acetyl-β-D-glucosamine residues joined by sequential (1→2)- and (1→3)-linkages.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc

Phenotype where environments contain alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc

Phenotype modified by environments containing alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc

Phenotype affecting alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc

Human Disease Model